Trial of Dasatinib in Advanced Sarcomas
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Scott Schuetze, MD, PhD
University of Michigan
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
20 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Arkansas Children'S Hospital
Little Rock, Arkansas, United States
- City of Hope
Duarte, California, United States
- Cedars-Sinai Outpatient Cancer Center
Los Angeles, California, United States
- Stanford University
Palo Alto, California, United States
- Sarcoma Oncology Center
Santa Monica, California, United States
- Washington Cancer Institute
Washington D.C., District of Columbia, United States
- Winship Cancer Institute at Emory University
Atlanta, Georgia, United States
- Kootenai Cancer Center
Coeur d'Alene, Idaho, United States
- Oncology Specialists
Park Ridge, Illinois, United States
- Indiana University Cancer Center
Indianapolis, Indiana, United States
- University of Iowa Hospitals and Clinics
Iowa City, Iowa, United States
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Baltimore, Maryland, United States
- Dana Farber Cancer Institute
Boston, Massachusetts, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- University of Michigan
Ann Arbor, Michigan, United States
- Nebraska Methodist Hospital
Omaha, Nebraska, United States
- Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States
- Pennsylvania Oncology Hematology Associates
Philadelphia, Pennsylvania, United States
- University of Pittsburgh Cancer Institute
Pittsburgh, Pennsylvania, United States
- Md Anderson
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2007
- Primary completion
- 31 Dec 2016
- Completion
- 31 May 2017
- Last update posted
- 23 Nov 2018
- Registered enrollment
- 366
- Registry id
- NCT00464620
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.